Delivery Order SPE2DB25D3201-SPE2DB26FNNMJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 29, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery under the company's existing relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (quantity: 28 units) on September 4, 2025. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 25, 2025, with fulfillment occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating that AmerisourceBergen competed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count package) on September 22, 2025, with completion expected by October 14, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (quantity 28) on July 11, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside contract represents a direct pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location, reflecting the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, for the supply of Tasigna 200 mg capsules (28-count units) with a contract ceiling value of $12,015.80. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and no set-aside designation was used. The award was competitively procured and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $18,023.70. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tasigna 200 mg capsules (28-count units) on September 15, 2025, with an ultimate completion date of October 6, 2025. The contract is unclassified with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a critical vendor in the federal medical procurement supply...
- The Defense Logistics Agency awarded a $18,023.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) on September 28, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNMJDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,015.80 on October 21, 2025, for the supply of Tasigna 150 mg capsules (28-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by November 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical prime vendor agreement valued at $999.99 million and extending through December 2026. As a child delivery order under this larger vehicle, the Tasigna procurement exemplifies the types of specialty pharmaceutical products the contractor regularly supplies to support military healthcare programs and other federal medical systems. AmerisourceBergen's competitively awarded contract portfolio with DLA demonstrates its established capability to fulfill diverse federal pharmaceutical requirements across multiple therapeutic domains on a firm fixed-price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 10/21/25 |